Medical Condition News

RSS

Epilepsy 'treatment gap' in Sierra Leone a result of stigma, lack of resources, experts say

In Sierra Leone, "one of Africa's poorest countries, ... scarce health care resources and the stigma surrounding epilepsy add up to a 'treatment gap' of more than 90 percent -- meaning that fewer than 10 percent of the estimated 60,000 to 100,000 Sierra Leoneans with epilepsy are getting the treatment they need," the New York Times reports.

31 Aug 2011

Yoga as therapy in neuropsychiatric disorders

Yoga is commonly seen as a practice beneficial to body and mind. Increasingly, yoga is being taken a step further and applied as a form of complementary and alternative medicine in treating psychiatric disorders.

31 Aug 2011

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Pearl Therapeutics Inc. today announced positive results from a randomized, double-blind, Phase 2b, dose-ranging study of its formoterol fumarate metered dose inhaler (FF MDI; PT005), a long-acting beta-2 agonist (LABA) compared to placebo and Foradil Aerolizer in patients with moderate-to-severe COPD.

31 Aug 2011

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Ketoconazole Foam, 2%, the generic version of Extina Ketoconazole Foam, 2%.

31 Aug 2011

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Aeterna Zentaris Inc. today announced favorable top-line results of its completed Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency.

31 Aug 2011

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.

30 Aug 2011

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.

30 Aug 2011

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Radiation can make cancer cells resistant to radio- and chemotherapy. University of Oslo researchers have now figured out how resistance can be switched on and off.

30 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

30 Aug 2011

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity

BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.

30 Aug 2011

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Two scientists developed a new drug that helped pioneer the era of "personalized medicine" for cancer patients, an approach in which one-size-fits-all drugs yield to medicines customized to the genetic endowment of individual patients. Another scientist invented today's predominant technology for genetic sequencing, deciphering the genetic blueprint in the DNA that makes up the genes of living things.

30 Aug 2011

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

Primary PCI is the best reperfusion therapy for patients presenting with acute ST-elevation myocardial infarction. CJ Terkelsen and co-workers used the Western Denmark Heart Registry to describe the implementation of primary PCI in Denmark.

30 Aug 2011

CMR predicts increased risk of sudden cardiac death in patients with myocardial infarction

Universitätsmedizin Berlin and Universität Leiden developed a method to identify a subgroup of patients with myocardial infarction that is at increased risk for sudden cardiac death.

30 Aug 2011

Postoperative outcomes of VAD bridged patients are worse than conventional therapy

Postoperative outcomes of severe heart failure patients bridged with short-term VADs to urgent heart transplantation are significantly worse than those of patients bridged with conventional support, recent data of the Spanish National Heart Transplant Registry suggest.

30 Aug 2011

IntraPace to launch new lifestyle management portal and support network at IFSO 2011 congress

IntraPace, Inc., the developer of the innovative abiliti implantable obesity management system, announced today that it will launch its new lifestyle management portal and support network this week at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg, Germany.

30 Aug 2011

Daily remote ICD monitoring a safe alternative to conventional follow-up

Device management using a home monitoring system with daily telemetry in patients with ICDs is a safe alternative to conventional monitoring and could decrease the number of inappropriate shocks, according to results of the ECOST study, a multicentre randomised trial performed in France.

30 Aug 2011

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

30 Aug 2011

Balloon pump use prior to PCI does not reduce infarct size in STEMI patients without shock

Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction (CRISP AMI) trial.

30 Aug 2011

Viewpoints: Spotlight on insurance industry; local health costs rising; obesity debate

The GOP candidate's positions are not a vision of the future for the U.S. but of a discredited past. ... Perry's proposed fixes for the healthcare system -; tort reform, individual ownership of health insurance, portability of plans for people who move or change jobs -; would do nothing to slow the growth of healthcare costs or reduce the number of uninsured Americans.

30 Aug 2011

Medical Condition News

Epilepsy 'treatment gap' in Sierra Leone a result of stigma, lack of resources, experts say

Yoga as therapy in neuropsychiatric disorders

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

CMR predicts increased risk of sudden cardiac death in patients with myocardial infarction

Postoperative outcomes of VAD bridged patients are worse than conventional therapy

IntraPace to launch new lifestyle management portal and support network at IFSO 2011 congress

Daily remote ICD monitoring a safe alternative to conventional follow-up

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

Balloon pump use prior to PCI does not reduce infarct size in STEMI patients without shock

Viewpoints: Spotlight on insurance industry; local health costs rising; obesity debate

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News